Corpus overview


MeSH Disease

Human Phenotype

There are no HP terms in the subcorpus



There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    The reflection on an AIDS MESHD patient with asymptomatic TRANS COVID-19 

    Authors: Rongrong Yang; Xien Gui; Shicheng Gao; Pingzheng Mo; Hengning Ke; Yongxi Zhang; Yong Xiong

    doi:10.21203/ Date: 2020-03-21 Source: ResearchSquare

    We reported the process of exposure, clinical characteristics, diagnosis and prognosis of an A IDS MESHDpatient with asymptomatic TRANS COVID-19. In our report, we found the asymptomatic TRANS is still shedding virus for at least 29 days. Therefore, we suggested that for individuals who had close contact TRANS with diagnosed or suspected COVID-19 patients, in addition to isolation, medical observation, and further related testing if clinical symptoms appear in the observation period, it is best to collect nasopharyngeal and throat swab specimens and test for COVID-19 nucleic acid as early as possible. The purpose of this active detection is to screen out COVID-19 asymptomatic patients, and to avoid further transmission TRANS through recessive source of i nfection. MESHD Our findings will facilitate understanding of asymptomatic TRANS COVID-19 and improve prevention strategies against COVID-19 transmission. 

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.